Related Experiment Video
Updated: May 24, 2026
07:04
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Norgestrel may be a potential therapy for retinal degenerations
Expert Opinion on Investigational Drugs
|March 2, 2012
Summary
Progestogenic hormones show promise for treating inherited retinal degeneration, like retinitis pigmentosa. These natural hormones may activate retinal pro-survival pathways, offering a new therapeutic avenue.
Area of Science:
- Ophthalmology
- Neuroendocrinology
- Genetics
Background:
- Retinal degenerations, including retinitis pigmentosa, are a diverse group of untreatable inherited disorders.
- Genetic complexity and variability hinder effective treatment development for these conditions.
- Current research explores novel therapeutic strategies beyond gene therapy and stem cells.
Discussion:
- Steroid hormones, particularly progestogens, are emerging as potential therapeutic agents for central nervous system (CNS) disorders.
- Progestogenic hormones are believed to influence retinal pro-survival pathways.
- Their endogenous production and potential neuroprotective roles warrant further investigation.
Key Insights:
- Progestogens modulate pro-survival pathways, suggesting a therapeutic role in retinal degeneration.
- Natural hormones offer a potentially valuable therapeutic approach due to their inherent biological functions.
- Understanding progestogen effects in the brain and retina is crucial for developing new treatments.
Outlook:
- Further research into progestogen mechanisms in the retina could lead to novel treatments for inherited retinal degenerations.
- Investigating the therapeutic potential of progestogenic hormones may offer new hope for patients with untreatable retinal disorders.
- This research opens avenues for exploring other neurosteroids in ophthalmology.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...